000 | 01771 a2200445 4500 | ||
---|---|---|---|
005 | 20250512023717.0 | ||
264 | 0 | _c19871223 | |
008 | 198712s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.84.22.8160 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aReinhard, J F | |
245 | 0 | 0 |
_aSubcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cNov 1987 |
||
300 |
_a8160-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
650 | 0 | 4 | _a1-Methyl-4-phenylpyridinium |
650 | 0 | 4 |
_aAdrenal Medulla _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium _xpharmacology |
650 | 0 | 4 |
_aCatecholamines _xanalysis |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 | _aCell Compartmentation |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDesipramine _xpharmacology |
650 | 0 | 4 |
_aDigitonin _xpharmacology |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aNicotine _xpharmacology |
650 | 0 | 4 |
_aPyridines _xpharmacokinetics |
650 | 0 | 4 |
_aPyridinium Compounds _xmetabolism |
650 | 0 | 4 |
_aSubcellular Fractions _xanalysis |
650 | 0 | 4 |
_aTetrabenazine _xpharmacology |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xantagonists & inhibitors |
700 | 1 | _aDiliberto, E J | |
700 | 1 | _aViveros, O H | |
700 | 1 | _aDaniels, A J | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 84 _gno. 22 _gp. 8160-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.84.22.8160 _zAvailable from publisher's website |
999 |
_c2896983 _d2896983 |